(Q34308923)

1 August 2017

1 reference

title

Betablocker treatment in diabetes mellitus (English)

1 reference

1 August 2017

Sawicki PT

1

1 reference

PubMed ID

11454137

1 August 2017

Siebenhofer A

series ordinal

2

1 reference

PubMed ID

11454137

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Journal of Internal Medicine

1 August 2017

1 reference

1 August 2017

250

1 reference

1 August 2017

1

1 reference

1 August 2017

11-17

1 reference

The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus.

1 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Guidelines for management of hypertension: report of the third working party of the British Hypertension Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Diabetic patients and beta-blockers after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Diabetes and decline in heart disease mortality in US adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

The effect of metoprolol treatment on insulin sensitivity and diurnal plasma hormone levels in hypertensive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Long term propranolol treatment and changes in body weight after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Can insulin-treated diabetics be given beta-adrenergic blocking drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Higher Glycemic Thresholds for Symptoms During β-Adrenergic Blockade in IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

The metabolic consequences of adrenergic blockade: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Measuring progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Effects of Converting-Enzyme Inhibition on Barrier Function in Diabetic Glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Renal protective effect of enalapril in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

Stabilization of glomerular filtration rate over 2 years in patients with diabetic nephropathy under intensified therapy regimens. Diabetes Treatment and Teaching Programmes Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00829.X

10.1046/J.1365-2796.2001.00829.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11454137